JRSH
Jerash Holdings (US), Inc.
JRSH has the edge over RIVN overall, supported by stronger fundamentals and lower modeled downside.
RIVN
Rivian Automotive, Inc.
RIVN's outlook is improving, though it still trails on the overall score.
JRSH Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Stable | |
| Strong |
JRSH's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
RIVN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
RIVN's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
JRSH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 8.4x | $4.11 | -44% |
| Fair | 14x | $6.75 | -8.1% |
| Current | 15x | $7.35 | — |
| Forward | 15x | $7.35 | — |
| Expensive | 26x | $12.70 | +73% |
Historical ranges are pointers, not guarantees.
JRSH's PE is in its fair range at 15.0x. On analysts' estimates for next year's earnings, today's price would be 15.2x.
RIVN PE Valuation
RIVN has no meaningful PE right now: it lost money over the past year.
JRSH Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for JRSH, with profitability improving.
RIVN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect RIVN's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
JRSH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.49 | -1% |
| Q3 2026 | $0.49 | +717% |
| Q2 2026 | $0.37 | +429% |
| Q1 2026 | $0.27 | +$0.34 |
| Q4 2025 | $0.15 | +$0.46 |
| Q3 2025 | $0.06 | +$0.35 |
| Q2 2025 | $0.07 | +$0.38 |
| Q1 2025 | -$0.07 | +$0.09 |
| Q4 2024 | -$0.31 | -$0.24 |
JRSH has the edge over RIVN on earnings quality, reporting a profit while its opponent remains loss making.
RIVN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.25 | +$0.83 |
| Q2 2026 | -$2.58 | +$0.62 |
| Q1 2026 | -$2.92 | +$0.77 |
| Q4 2025 | -$3.07 | +$1.62 |
| Q3 2025 | -$3.08 | +$2.52 |
| Q2 2025 | -$3.20 | +$2.76 |
| Q1 2025 | -$3.69 | +$2.08 |
| Q4 2024 | -$4.69 | +$1.05 |
RIVN is still losing money, but far less than before: $2.25 per share over the past year, against $7.40 at its worst in late 2022.
JRSH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $50.3M | +20% |
| Q2 2026 | $50.2M | +27% |
| Q1 2026 | $42.9M | +47% |
| Q4 2025 | $41.8M | +18% |
| Q3 2025 | $42M | +4.3% |
| Q2 2025 | $39.6M | -3.2% |
| Q1 2025 | $29.3M | +36% |
| Q4 2024 | $35.4M | +29% |
JRSH has the edge over RIVN on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 6.1% | +3.5 points |
| Q2 2026 | 5.2% | +2.8 points |
| Q1 2026 | 5.5% | +4 points |
| Q4 2025 | 4.7% | +2.7 points |
| Q3 2025 | 2.6% | -0.2 points |
| Q2 2025 | 2.4% | +4.4 points |
| Q1 2025 | 1.5% | +16 points |
| Q4 2024 | 2% | +0.6 points |
JRSH has the edge over RIVN on profitability, with a higher operating margin.
RIVN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2.2B | +38% |
| Q2 2026 | $1.7B | +27% |
| Q1 2026 | $1.4B | +11% |
| Q4 2025 | $1.3B | -26% |
| Q3 2025 | $1.6B | +78% |
| Q2 2025 | $1.3B | +13% |
| Q1 2025 | $1.2B | +3% |
| Q4 2024 | $1.7B | +32% |
RIVN's revenue is growing: $2.2B last quarter, up 38% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -41% | +22 points |
| Q2 2026 | -50% | +35 points |
| Q1 2026 | -64% | -11 points |
| Q4 2025 | -65% | -27 points |
| Q3 2025 | -63% | +71 points |
| Q2 2025 | -86% | +33 points |
| Q1 2025 | -53% | +70 points |
| Q4 2024 | -38% | +82 points |
RIVN's operating margin was −41% last quarter, up 22 points from the same quarter a year ago, near the top of its range since 2021.
JRSH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.4M | -32% |
| Q2 2026 | $2.3M | +$9.3M |
| Q1 2026 | $1.8M | +21% |
| Q4 2025 | -$3.9M | -$750.5K |
| Q3 2025 | $6.4M | +46% |
| Q2 2025 | -$6.9M | -$4.6M |
| Q1 2025 | $1.5M | +$7.3M |
| Q4 2024 | -$3.2M | -$2.7M |
JRSH has the edge over RIVN on cash generation, producing positive trailing cash flow while its opponent burns cash.
RIVN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.1B | -$703M |
| Q2 2026 | -$849M | -$451M |
| Q1 2026 | -$1.1B | -$549M |
| Q4 2025 | -$1.1B | -234% |
| Q3 2025 | -$421M | +$732M |
| Q2 2025 | -$398M | +$639M |
| Q1 2025 | -$526M | +$997M |
| Q4 2024 | $856M | +$2.3B |
RIVN has burned cash in almost every quarter: −$4.2B over the past year, against −$489M the year before.
JRSH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.3x | Net Cash |
| Q2 2026 | -1.1x | Net Cash |
| Q1 2026 | -1.2x | Net Cash |
| Q4 2025 | -0.7x | Net Cash |
| Q3 2025 | -2.6x | Net Cash |
| Q2 2025 | -0.3x | Net Cash |
| Q1 2025 | -4.6x | Net Cash |
| Q4 2024 | -13.3x | Net Cash |
JRSH has more cash than debt.
RIVN Net Leverage
RIVN's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
JRSH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 84.7 | Overbought |
| Stochastic | 74.8 | Neutral |
JRSH's weekly RSI is 85 (overbought) and its Stochastic is 75 (neutral).
RIVN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.5 | Neutral |
| Stochastic | 25.6 | Neutral |
RIVN's weekly RSI is 41 (neutral) and its Stochastic is 26 (neutral).
JRSH PE vs Consumer Cyclical Sector
| Metric | JRSH | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 18x | 17% below |
| PE % | 58 | 47 | 11 pts above |
JRSH is trading at 15x earnings, a 17% discount to the Consumer Cyclical sector's median of 18x.
RIVN PE vs Consumer Cyclical Sector
RIVN has no meaningful PE right now: it lost money over the past year.
JRSH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $6.21 | 18% above |
| 20 week MA | $5.50 | 34% above |
| 50 week MA | $4.16 | 77% above |
| 100 week MA | $3.75 | 96% above |
| 200 week MA | $3.60 | 104% above |
JRSH has the edge over RIVN on trend strength, trading above more of its moving averages.
RIVN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $13.3 | 3.9% below |
| 20 week MA | $15.1 | 15% below |
| 50 week MA | $15.9 | 19% below |
| 100 week MA | $14.7 | 13% below |
| 200 week MA | $15.1 | 15% below |
RIVN is in a downtrend: it's below all five of its weekly moving averages, and 15% below its 200-week average.
JRSH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $6.02 | $5.52 | -8.3% |
| 2021 | $5.52 | $6.70 | +21% |
| 2022 | $6.70 | $4.03 | -40% |
| 2023 | $4.03 | $3.11 | -23% |
| 2024 | $3.11 | $3.43 | +10% |
| 2025 | $3.43 | $3.03 | -12% |
| 2026 YTD | $3.03 | $7.35 | +143% |
JRSH has the edge over RIVN on returns for 2026, with the stronger performance.
RIVN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $130.0 | $96.8 | -25% |
| 2022 | $96.8 | $19.1 | -80% |
| 2023 | $19.1 | $23.5 | +23% |
| 2024 | $23.5 | $13.7 | -42% |
| 2025 | $13.7 | $20.9 | +53% |
| 2026 YTD | $20.9 | $12.8 | -39% |
RIVN has finished lower in three of the last five years. It's down 39% so far in 2026.